61 reports

Global Non-Opioid Pain Relief Device Market: Focus on Application, Technology, End-User, Competitive Landscape – Analysis and Forecast, 2018-2029 ## Market Overview ##. ## Pain Management Overview ##. ## Pain Management by Usage of Opioid Drugs ##. ## Pain Management by

  • Opioid
  • Pain Relief
  • Therapy
  • World
  • Forecast

Topical Pain Relief Market - Global Opportunity Analysis and Industry Forecast, 2018-2025 CHAPTER ##: INTRODUCTION ##. ##.

  • OTC
  • Pain Relief
  • APAC
  • World
  • Market Size

Topical Pain Relief Market by Therapeutic Class, Type, Formulation and Distribution Channel - Global Opportunity Analysis and Industry Forecast, 2018-2025 CHAPTER ##: INTRODUCTION ##. ##.

  • OTC
  • Pain Relief
  • APAC
  • World
  • Market Size

Topical Pain Relief Market by Therapeutic Class, Type, Formulation, and Distribution Channel: Opportunity Analysis and Industry Forecast, 2018-2025 CHAPTER ##: INTRODUCTION ##. ##.

  • Pain Relief
  • Pharmaceutical
  • United States
  • Forecast
  • Market Segment
  • Identifying factors impacting market growth

The overdose of pain-relief medicines can also lead to migraine.

  • Pain Relief
  • Allergan plc
  • Amgen Inc.
  • Eli Lilly & Co Ltd
  • Eli Lilly & Co.
  • EXECUTIVE SUMMARY
  • Major market segmentation (2018-19)

The industry also includes other nonprescription pain-relief products.

  • Analgesic
  • OTC
  • Pain Relief
  • Therapy
  • Demand
  • 7.1.5 RIZAPORT (RIZATRIPTAN BENZOATE)
  • 6.5 JAPAN

SUBJECTS REPORTED PAIN RELIEF IN LESS THAN ## MINUTES, WITH ##% OF SUBJECTS REPORTING PAIN RELIEF WITHIN ONE HOUR OF ADMINISTRATION OF A SINGLE ##MG SUBCUTANEOUS DOSE OF IMITREX INJECTION.

  • Pain Relief
  • Allergan plc
  • Amgen Inc.
  • Eli Lilly & Co.
  • Pfizer Inc.
  • common side effect was medication after taste and nausea in
  • Improvement at two hours in people who took LEVADEX compared to Placebo (2nd pivotal trial)

Figure ##: ## hour pain relief & pain free rates in patients treated with LEVADEX (MAP##) compared to placebo (##st pivotal trial) FREEDOM-## Results : Semprana/ Levadex Pivotal Clinical Trials and Results ≤## hour > ## to ≤## hours > ##

  • Clinical Trial
  • Pain Relief
  • World
  • Forecast
  • Allergan plc
  • Market challenges

In 2016, the OTC medicines market reached $##. ## billion in the US alone, where the pain relief segment accounted for ##. ##% of overall market share.

  • Pain Relief
  • World
  • Market Size
  • Sigma-Aldrich
  • Thermo Fisher Scientific, Inc.
  • 2.6 Comorbidities and Complications

This class of drugs provides potent pain relief.

  • Pain Relief
  • Market Size
  • Allergan plc
  • Amgen Inc.
  • Depomed, Inc.
  • ANTI-MIGRAINE DRUGS
  • Sales of Top Anti-Migraine Products in 2017

The company' s Respiratory and Personal Care include Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp and ChapStick.

  • Hospital
  • Pain Relief
  • AstraZeneca PLC
  • Lilly Endowment Inc.
  • Pfizer Inc.

No Relief, by Treatment, 2016 The role of food, vitamin and home treatments Table ##-##: Food, Vitamin and Home Treatments Used to Treat Pain: Got Relief vs.

  • OTC
  • Pain Relief
  • DATA PARAMETERS AND REPORT DEFINITIONS (1)
  • REPORT DEFINITIONS (2)

Ibuprofen: Indicated for pain, inflammation and fever, ibuprofen is an NSAID (nonsteroidal anti- Ketoprofen: This is used for the relief of pain and inflammation in rheumatic disease and other musculoskeletal disorders.

  • Pain Relief
  • Demand
  • Bayer AG
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • OPPORTUNITIES IN REFORMULATION
  • Data parameters and report definitions (1)

Different brands accomplish this in different ways: Aleve (Bayer AG), for example, opts for extendedrelease action in its tablets, delivering ## hours of pain relief in one dose of ##mg of naproxen sodium, building on its consistent message of " all day pain

  • Analgesic
  • Pain Relief
  • Therapy
  • World
  • Demand

THE NEED FOR SELF-ADMINISTRATION IS EVIDENT IN EMERGENCY SITUATIONS AND IN CONDITIONS, SUCH AS LIFETHREATENING ALLERGY INDICATIONS, IMMEDIATE PAIN RELIEF FOR WOUNDED MILITARY PERSONNEL DURING WARTIME AND SEVERAL OTHER CONDITIONS.

  • Neurological Disorder
  • Pain Relief
  • World
  • Forecast
  • Antares Pharma, Inc.

Rising purchase of generic drugs in the Indian market INDIA PAIN MANAGEMENT DRUGS MARKET Rising incidences of chronic pain in the country is one the major factor towards the increasing purchase of generic drugs for relief of pain falling in the category of musculo

  • Pain Relief
  • World
  • AstraZeneca PLC
  • Endo International plc
  • Pfizer Inc.
  • INTRODUCTION
  • REGIONAL OVERVIEW

Sports players also show strong demand for topical pain relief.

  • Analgesic
  • Pain Relief
  • Eastern Europe
  • Demand
  • Forecast
  • REGIONAL OVERVIEW

PASSPORT ## STEADY REGIONAL GROWTH DRIVEN BY CHINA REGIONAL OVERVIEW The accelerated ageing of the population in China and Japan contributed to the region' s steady growth over the past ## years, as elderly consumers consider pain relief the major and first problem to solve and

  • Pain Relief
  • APAC
  • China
  • Kowa Co., Ltd.
  • Sanofi S.A.

Pain Relieving Drugs Market Forecast 2017-2027 ##.

  • OTC
  • Pain Relief
  • World
  • Forecast
  • Market Shares
  • LEADING COMPANIES AND BRANDS

Additionally, the company continues to innovate around Nurofen, with Nurofenteen Menta (mint) in Italy, an orodispersible (dissolves in the mouth without the use of water) mint flavoured brand variants targeting teenagers, and its ##-hr Nurofen pain relief patch in the UK for joint

  • Pain Relief
  • Germany
  • Russia
  • Western Europe
  • Demand
  • BAYER HEALTHCARE: YOY REVENUE AND GROWTH RATE OF ASPIRIN 2013-2015 ($ MILLIONS)
  • BAYER HEALTHCARE

These are designed particularly for pain relief.

  • Pain Relief
  • World
  • Bayer AG
  • Pfizer Inc.
  • Sanofi S.A.

(USA) ##.

  • Pain Relief
  • China
  • United States
  • Demand
  • Market Shares

(USA) ##.

  • Opioid
  • Pain Relief
  • Therapy
  • United States
  • Market Shares
  • PAIN RELIEF DEVICE - PRODUCT STATUS
  • PAIN RELIEF DEVICE - PRODUCT DESCRIPTION

The company" s products for pain relief include ActiPatch, an OTC treatment for musculoskeletal pain reliefSmart Insole, for relief from heel painAllay, a menstrual pain therapy RecoveryRx, for relief from pain in chronic wounds and postopera

  • Clinical Trial
  • Drug Development
  • Pain Relief
  • United States
  • Sanofi S.A.
  • ALLAY MENSTRUAL PAIN RELIEF PATCH - PRODUCT DESCRIPTION
  • ALLAY MENSTRUAL PAIN RELIEF PATCH - PULSED ELECTROMAGNETIC FIELD TREATMENT FOR PAINFUL PERIODS: A RANDOMIZED CONTROL TRIAL

THE COMPANY' S PRODUCTS FOR PAIN RELIEF INCLUDE ACTIPATCH, AN OTC TREATMENT FOR MUSCULOSKELETAL PAIN RELIEF; SMART INSOLE, FOR RELIEF FROM HEEL PAIN; ALLAY, A MENSTRUAL PAIN THERAPY; RECOVERYRX, FOR RELIEF FROM PAIN IN CHRON

  • Chronic Pain
  • Clinical Trial
  • Pain Relief
  • Therapy
  • BioElectronics Corporation
  • Aqualis Completes Rights Offering Of Shares For US$9 Million
  • Aqualis Completes Private Placement Of Shares For US$4 Million

Weifa is a provider of consumer health pain relief products and supplier of API for diabetes medicine and opiates for use in pain relief and cough medicine.

  • Pain Relief
  • Norway
  • Company Financials
  • M&A
  • Weifa
  • Aug 14, 2019: Zosano Pharma files IND to Initiate a phase 2/3 Clinical Study in Cluster Headache
  • registered with the U.S. National Institutes of Health.

A key secondary endpoint of this trial is pain relief at ## min, aimed at demonstrating the rapid relief profile of M##.

  • Pain Relief
  • Therapy
  • United States
  • Product Initiative
  • Zosano Pharma Corporation
  • SEP 05, 2008: NEURAXON'S NXN-188 DEMONSTRATES PAIN RELIEF IN MIGRAINE WITH AURA
  • Neurophyxia B.V. is an innovative clinical stage drug development company, focusing on disorders affecting the newborn child announces the start of formal preclinical development of 2-IB (manufacturing and safety studies).

Study ## reported pain relief as early as ## minutes after dosing, and relief was sustained across the migraine episode.

  • Pain Relief
  • United States
  • World
  • Product Initiative
  • NeurAxon, Inc.
  • SEP 05, 2008: NEURAXON'S NXN-188 DEMONSTRATES PAIN RELIEF IN MIGRAINE WITH AURA
  • FEB 29, 2012: NEUROPHYXIA PROVIDES UPDATE ON 2-IMINOBIOTIN

Study ## reported pain relief as early as ## minutes after dosing, and relief was sustained across the migraine episode.

  • Pain Relief
  • Therapy
  • United States
  • Product Initiative
  • NeurAxon, Inc.
  • Clinical Trial profile. 195 Trial Title
  • Clinical Trial profile. 222 Trial Title

In Healthy Male and Female Subjects under Fasting Condition GDCT## GDC##, Women' s Health Back Pain, Dysmenorrhea, Joint Pain, Musculoskeletal Pain, Pain Completed Phase I Interventional naproxen PharmaSwiss Ceska Republika sro A Bioequivalence Stud

  • Anti Rheumatic
  • Pain Relief
  • Pharmaceutical
  • World
  • Product Initiative